A detailed history of Engineers Gate Manager LP transactions in Morpho Sys Ag stock. As of the latest transaction made, Engineers Gate Manager LP holds 13,416 shares of MOR stock, worth $0. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,416
Previous 13,416 -0.0%
Holding current value
$0
Previous $243,000 0.41%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$8.6 - $18.18 $115,377 - $243,902
13,416 New
13,416 $243,000
Q3 2023

Nov 14, 2023

BUY
$6.72 - $8.6 $73,362 - $93,886
10,917 New
10,917 $73,000

Others Institutions Holding MOR

About MorphoSys AG


  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.